Role of H 2 receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial.
World journal of clinical cases(2022)
Abstract
According to our study, treatment with famotidine achieved a better clinical outcome compared to the control group in severe COVID-19 illness, although no significant survival benefit was found.
MoreTranslated text
Key words
Bangladesh,COVID-19,COVID-19 acute respiratory distress syndrome,COVID-19 treatment,Famotidine,SARS-CoV-2
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined